找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Case-Based Gynecological Oncology; Kavita Singh,Bindiya Gupta Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive l

[复制链接]
楼主: 磨损
发表于 2025-3-30 10:48:02 | 显示全部楼层
发表于 2025-3-30 15:05:49 | 显示全部楼层
Diagnostic Pathways of Postmenopausal Bleedingndometrial sampling with or without hysteroscopy is recommended. Hysteroscopy is offered to women with ET of ≥10 mm, focal lesion on TVS, recurrent PMB irrespective of the ET, or inadequate endometrial biopsy.
发表于 2025-3-30 17:02:12 | 显示全部楼层
发表于 2025-3-30 22:02:04 | 显示全部楼层
发表于 2025-3-31 01:14:53 | 显示全部楼层
Management of Adnexal Massese an adnexal mass into possibly benign or malignant. The IOTA simple rules and ORADS are two classification systems for adnexal masses on imaging. Tumor markers play an important role to determine the presence and type of malignant ovarian mass. Various triaging models like Risk of malignancy index,
发表于 2025-3-31 08:29:21 | 显示全部楼层
发表于 2025-3-31 09:20:33 | 显示全部楼层
发表于 2025-3-31 13:46:43 | 显示全部楼层
Platinum Resistant Ovarian Cancerlth related quality of life and use of maintenance therapy with bevacizumab and PARP inhibitors. Treatment of early recurrence (<6 months of completion of primary chemotherapy) usually consists of single agent non platinum drugs like liposomal doxorubicin, paclitaxel, etoposide and the overall respo
发表于 2025-3-31 19:40:09 | 显示全部楼层
Metastatic Ovarian Canceristochemistry especially using CK7 and CK20 are the most commonly used antigens in differentiating between primary and metastatic ovarian tumours. Genetic testing is crucial for counselling and tailoring management. Treatment is mainly palliative chemotherapy while in select cases metastatectomy or
发表于 2025-4-1 00:42:39 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-19 02:12
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表